Viewing Study NCT01704495


Ignite Creation Date: 2025-12-24 @ 1:41 PM
Ignite Modification Date: 2026-01-07 @ 7:02 AM
Study NCT ID: NCT01704495
Status: COMPLETED
Last Update Posted: 2016-03-01
First Post: 2012-10-09
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Phase II Study to Evaluate the Efficacy, Safety and Tolerability of AZD5069 in Patients With Uncontrolled Persistent Asthma.
Sponsor: AstraZeneca
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Asthma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Uncontrolled Asthma, View
None Exacerbation, View
None Safety View